Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SeaSpine, Inc.
A prospective, single-center, clinical study evaluating patients undergoing primary, contiguous 2-level ALIF without supplemental fixation treated with Demineralized Bone Matrix (DBM) as compared to a Cellular Bone Matrix (CBM).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥18 years of age
Requires anterior lumbar interbody (ALIF) fusion
Are physically and mentally able and willing to return for the scheduled follow up visits, follow post-operative instructions
Willing and able to sign study specific Informed Consent Form
You may not be if
Signs of acute infection
Active malignancy and/or current chemotherapy
Prior fusion at operative or adjacent level
Institutionalized or a prisoner
Documented history of alcohol or drug abuse
Undergoing a worker's compensation case
Pregnancy
Participation in another research study involving another implant or drug that may affect the outcomes of this clinical study
Any other condition that the Investigator determines is unacceptable for enrollment into this clinical study
